August 7, 2024 01:57 PM EDT
Pharma
Law

UPenn sues BioN­Tech, says it owes 'sig­nif­i­can­t' Covid-re­lat­ed roy­al­ties

Nicole DeFeudis

Editor

The Uni­ver­si­ty of Penn­syl­va­nia is bring­ing BioN­Tech to court over roy­al­ties the school be­lieves it’s owed on the com­pa­ny’s Pfiz­er-part­nered Covid vac­cine.

In a law­suit …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

Out­look's shares crash as wet AMD drug flunks Phase 3 test

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

A service from the Financial Times